Previous studies have shown that supplier-dependent differences in the GM significantly influence disease phenotypes in several disease models, such as the IL10−/− mouse model of inflammatory bowel disease (IBD) and the Apc+/min mouse model of colorectal cancer4,5. This evidence concerns the gene APC and inflammatory bowel disease.